WWOX and myeloid sarcoma: WWOX-expressing cells were identified as being reduced in chronic active MS lesions [215], which are defined by accumulation of microglia and/or macrophages at the lesion edge, subtle opening of the blood-brain barrier, and repair/remyelination failure with axonal loss, and are associated with more aggressive MS [216].